Boxer-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
28
Total Value
332470540
Accession Number
0002018299-25-000002
Form Type
13F-HR
Manager Name
Boxer-Capital-Management
Data Enrichment
86% identified
24 identified4 unidentified

Holdings

28 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
Revolution Medicines, Inc.
Shares:1.3M
Value:$46.6M
Nuvalent, Inc.
Shares:450.0K
Value:$31.9M
Merus N.V.
Shares:700.0K
Value:$29.5M
Avidity Biosciences, Inc.
Shares:865.0K
Value:$25.5M
ANAPTYSBIO, INC
Shares:1.3M
Value:$24.2M
Xenon Pharmaceuticals Inc.
Shares:600.0K
Value:$20.1M
Replimune Group, Inc.
Shares:1.8M
Value:$17.5M
Apellis Pharmaceuticals, Inc.
Shares:713.0K
Value:$15.6M
16934W106
Shares:1.8M
Value:$15.4M
Tango Therapeutics, Inc.
Shares:10.4M
Value:$14.2M
Enliven Therapeutics, Inc.
Shares:671.4K
Value:$13.2M
Oric Pharmaceuticals, Inc.
Shares:1.7M
Value:$9.7M
Day One Biopharmaceuticals, Inc.
Shares:1.2M
Value:$9.4M
Kymera Therapeutics, Inc.
Shares:325.0K
Value:$8.9M
PROTHENA CORP PUBLIC LTD CO
Shares:690.0K
Value:$8.5M
uniQure N.V.
Shares:750.0K
Value:$8.0M
Legend Biotech Corp
Shares:200.0K
Value:$6.8M
Nurix Therapeutics, Inc.
Shares:563.1K
Value:$6.7M
Amylyx Pharmaceuticals, Inc.
Shares:1.8M
Value:$6.2M
Solid Biosciences Inc.
Shares:1.2M
Value:$4.6M